Search This Blog

Tuesday, August 13, 2019

Rubius Therapeutics EPS misses by $0.02

Rubius Therapeutics (NASDAQ:RUBY): Q2 GAAP EPS of -$0.50 misses by $0.02.
Press Release
https://seekingalpha.com/news/3491020-rubius-therapeutics-eps-misses-0_02
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)